Top 5 Key Players companies in Diabetic neuropathy by Highest Patent Value in the Italy in 2020 – Discovery

Free Trial

The Diabetic neuropathy top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Diabetic neuropathy Key Players in the Italy. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	CHIESI Farmaceutici SpA	Emilia-Romagna, Italy	Inhaler,Neonatology,Medicine, ...[+2]	Avg patent value: 44,000
2	Newron Pharmaceuticals SpA	Lombardia, Italy	Safinamide,Health care,Levodopa, ...[+2]	Avg patent value: 0
3	Rottapharm SpA	Lombardia, Italy	Pharmaceutics,Medicine,Orphan drug, ...[+2]	Avg patent value: 0
4	Alfasigma SpA	Emilia-Romagna, Italy	Internationalization,Gastrointestinal agent,Clinical trial, ...[+2]	Avg patent value: 0
5	Sigma-Tau Industrie Farmaceutiche Riunite SpA	Lazio, Italy	Clinical trial,Medicine,Scientific institution, ...[+2]	Avg patent value: 0

Page generation time: Dec 16 2025

Top 5 Key Players companies in Diabetic neuropathy
by Highest Patent Value in the Italy in 2020

Key Players

Fast-growings

Startups & Unicorns

New Entrants

2022

2021

2020

2019

2018

Global

China

Japan

India

Netherlands

Denmark

United States

United Kingdom

Germany

Switzerland

Spain

South Korea

Canada

France

Italy

Most Patent Filings

Highest Patent Value

Most Patent Citation

Who we serve

Why Discovery

Social media

Try Discovery